OR WAIT null SECS
November 13, 2026
Article
HIBISCUS showed a 48.7% vs 7.2% hemoglobin response at week 24, with an FDA decision expected in 2027.
November 05, 2026
Video
In ZIPS-2, 20 mg daily zinc reduced all-cause infection rates by 38% vs placebo in Ugandan children with sickle cell anemia aged
October 31, 2026
Stay updated with the latest healthcare breakthroughs, including new TRANSCEND-T2D-2 data and FDA actions.
October 30, 2026
The FDA has pushed its decision on mitapivat for sickle cell disease to February 1, 2027, while it reviews updated safety data to decide whether a REMS is needed.
October 12, 2026
How patient priorities shift from childhood to adulthood, and why separating subclinical bleeds from chronic pain remains an unmet need.
A treatment center director explains how point-of-care ultrasound separates subclinical bleeds from chronic joint pain.
October 09, 2026
Lasker Award winners Takehisa Kitazawa and Tomoyuki Igawa discuss prophylaxis gains, remaining unmet needs, and lessons for drug discovery.
Lasker Award winners Kunihiro Hattori, Takehisa Kitazawa, and Tomoyuki Igawa recount the 2400 variants behind the drug.
October 08, 2026
The guideline chair answers key questions on new ferritin cutoffs, symptoms without anemia, inflammation, and lab reporting.
October 07, 2026
New ASH guidelines set higher ferritin thresholds. The panel chair on building them into lab reports and when 50 ng/mL may fit.